查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
電子藥物/生物電醫學的全球市場：按產品（心臟心律調節器、ICD、人工電子耳、神經調節）、類型和應用 - 預測（截至 2029 年）
市場調查報告書
商品編碼
1452895

電子藥物/生物電醫學的全球市場：按產品（心臟心律調節器、ICD、人工電子耳、神經調節）、類型和應用 - 預測（截至 2029 年）

Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation ), Type, Application - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 382 Pages | 訂單完成後即時交付

價格
簡介目錄

電子藥物/生物電子醫學市場規模預計將從 2024 年的 239 億美元成長到 2029 年的 336 億美元，預測期內複合年成長率為 7.0%。

促進市場成長的主要因素包括對心律管理（CRM）設備研究的投資和資助增加、政府對神經系統疾病的支持和資助增加以及神經系統和心血管疾病的盛行率增加。人口老化導致死亡率上升。另一方面，電生理設備的高成本和高資本投資要求抑制了市場成長。

調查範圍
調查年份 2021-2029
基準年 2023年
預測期 2024-2029
單元 金額（美元）
部分 按產品類型/應用程式/地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東和非洲

在預測期內，視網膜植入產業預計將出現最高成長率：

視網膜植入有可能使患有色素性視網膜炎和老齡化黃斑部病變等視網膜退化性疾病的患者恢復視力，且其生長速度也加速。

預計非侵入性電子醫療設備領域在預測期內將具有最高的收益成長率：

這些設備不需要手術植入，而是使用電場或磁場來刺激身體表面的神經和肌肉。它使用方便、成本效益高、感染風險低。非侵入性電藥擴大用於治療慢性疼痛、神經病變和代謝紊亂。設備技術的進步、醫療保健支出的增加和慢性病盛行率的上升預計也將推動預測期內的成長。

亞太地區是成長最快的地區：

預計亞太地區在預測期內的複合年成長率最高。這一成長的推動因素包括醫療保健支出增加、藥物研發增加、政府努力意識提升、私立醫院向各國農村地區的擴張以及該地區存在高成長市場。這是因為

本報告調查了全球電子藥物/生物電子醫學市場，並提供了市場概況、市場影響因素和市場機會分析、技術和專利趨勢、法律制度、市場規模趨勢和預測以及各種分類。 ,編制詳細的區域分析，競爭格局、主要企業概況等

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 任務
    • 趨勢
  • 價格分析
  • 價值鏈分析
  • 供應鏈分析
  • 生態系分析
  • 波特五力分析
  • 監管狀況
  • 技術分析
  • 貿易分析
  • 專利分析
  • 重大會議及活動
  • 影響客戶業務的趨勢/干擾
  • 主要相關利益者和採購標準

第6章電子藥品市場：依產品

  • 心臟心律調節器和植入式心臟整流去顫器
  • 人工電子耳
  • 神經調節劑
    • 脊髓刺激設備
    • 深部腦部刺激器
    • 迷走神經刺激設備
    • 薦椎神經刺激
    • 胃電刺激設備
    • 經皮神經刺激設備
    • 經顱磁刺激器
    • 呼吸電刺激設備
    • 三叉神經興奮劑
    • 反應性神經興奮劑
  • 視網膜植入

第7章電子藥品市場：依類型

  • 植入式電醫療裝置
  • 非侵入性電療設備

第8章 電子藥品市場：依應用分類

  • 對於心臟心律調節器和 ICD：按應用分類
    • 心律不整
    • 心臟衰竭
    • 其他
  • 對於脊髓刺激設備：按應用
    • 慢性疼痛
    • 腰椎手術失敗綜合症
    • 缺血
  • 對於深部腦部刺激器：依應用分類
    • 帕金森氏症
    • 發抖
    • 憂鬱症
    • 其他
  • 對於薦骨神經刺激器：按應用
    • 尿失禁
    • 大便失禁
  • 對於迷走神經刺激設備：按應用
    • 癲癇
    • 其他
  • 對於胃電刺激設備：按應用
    • 胃輕癱
    • 肥胖
  • 對於經皮神經刺激設備：依應用
    • 抗治療性憂鬱症
    • 其他
  • 對於經顱磁刺激裝置：依應用
    • 憂鬱症
    • 偏頭痛
  • 對於呼吸電刺激設備：依應用
    • 脊髓損傷
  • 對於三叉神經刺激設備：按應用
    • 注意力不足/過動症
    • 偏頭痛

第9章 電子藥品市場：依地區

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第10章競爭格局

  • 概述
  • 主要企業/主要企業招募策略
  • 收益分析
  • 市場佔有率分析
  • 品牌/產品比較
  • 企業評價矩陣：主要企業
  • 企業足跡
  • 企業評估矩陣：Start-Ups/中小企業
  • 競爭基準化分析
  • 競爭場景

第11章 公司簡介

  • 主要企業
    • MEDTRONIC
    • BOSTON SCIENTIFIC CORPORATION
    • ABBOTT
    • LIVANOVA PLC
    • COCHLEAR LTD.
    • MICROPORT SCIENTIFIC CORPORATION
    • SONOVA
    • NEVRO CORP.
    • AXONICS, INC.
    • NEURONETICS
    • ELECTROCORE, INC.
    • NEUROPACE, INC.
  • 其他公司
    • BIOTRONIK
    • MEDICO SRL
    • ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
    • MED-EL
    • ALEVA NEUROTHERAPEUTICS
    • NEUROSIGMA, INC.
    • BIOWAVE CORPORATION
    • SOTERIX MEDICAL INC.
    • BIOINDUCTION (AMBER THERAPEUTICS)
    • GIMER MEDICAL
    • CEFALY
    • BIOCONTROL MEDICAL
    • TVNS HEALTH GMBH

第12章附錄

簡介目錄
Product Code: MD 4358

The global market for electroceuticals/bioelectric medicine is expected to grow to USD 33.6 billion by 2029, up from USD 23.9 billion in 2024, representing a CAGR of 7.0% during the forecast period. This growth is being primarily driven by several factors, including increased investments and funding for research on cardiac rhythm management (CRM) devices, rising government support and funding for neurological disorders, and the growing geriatric population, which is leading to a higher prevalence of neurological and cardiovascular disorders. However, the market's growth is being hindered by the high cost of electroceutical devices and the need for significant capital investments.

Scope of the Report
Years Considered for the Study2021-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD) Billion
SegmentsProduct, type, application, and region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

"The retinal implants segment accounted for the highest growth rate in the electroceuticals market, by product, during the forecast period"

Based on product, the electroceuticals market is segmented into cardiac pacemakers & implantable cardioverter defibrillators, neuromodulators, cochlear implants, and retinal implants. In 2022, the retinal implants segment accounted for the highest growth rate in the electroceuticals market. The main driving factor for retinal implants is the potential to restore vision in individuals with retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration.

"The non-invasive electroceuticals devices segment is projected to experience the highest revenue growth rate during the forecast period"

The electroceuticals market is divided into two segments: implantable electroceutical devices and non-invasive electroceutical devices. In 2022, the noninvasive electroceutical devices segment experienced the highest growth rate. These devices do not require surgical implantation; instead, they use electrical or magnetic fields to stimulate nerves or muscles on the body's surface. They are easy to use, cost-effective, and carry a lower risk of infection. Non-invasive electroceuticals are increasingly being used in the treatment of chronic pain, neurological disorders, and metabolic disorders. Technological advancements in non-invasive electroceuticals, along with increased healthcare expenditure and a rise in the prevalence of chronic diseases, are anticipated to drive the growth of the non-invasive devices segment in the forecast period.

"Asia Pacific: The fastest-growing region in electroceuticals care market"

The global electroceuticals market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to record the highest CAGR during the forecast period. This growth is attributed to factors such as increased healthcare expenditure, rising pharmaceutical research funding, government initiatives to raise awareness about early disease detection, expansion of private-sector hospitals into rural areas in various APAC countries, and the presence of high-growth markets in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 28%, Tier 2 - 42%, and Tier 3 -30%
  • By Designation: C-level - 30%, D-level - 34%, and Others - 36%
  • By Region: North America - 46%, Europe - 25%, Asia Pacific - 18%, and Rest of the World -11%

Lists of Companies Profiled in the Report:

  • Medtronic plc (Ireland)
  • Boston Scientific Corporation (US)
  • Abbott Laboratories, Inc. (US)
  • Cochlear Ltd. (Australia)
  • LivaNova PLC (UK)
  • MicroPort Scientific Corporation (China)
  • Sonova Group (Switzerland)
  • Nevro Corp. (US)
  • Axonics Modulation Technologies, Inc. (US)
  • Neuronetics, Inc. (US)
  • ElectroCore, Inc. (US)
  • NeuroPace, Inc. (US)
  • BIOTRONIK (Germany)
  • Medico S.p.A. (Italy)
  • Nurotron Biotechnology Co. Ltd. (US)
  • MED-EL (Austria)
  • Aleva Neurotherapeutics SA (Switzerland)
  • NeuroSigma, Inc. (US)
  • BioWave Corporation (US)
  • Soterix Medical Inc. (US)
  • Bioinduction (Amber Therapeutics) (UK)
  • GiMer Medical (Taiwan)
  • Cefaly (Belgium)
  • BioControl Medical (Israel)
  • tVNS Technologies GmbH (Germany).

Research Coverage:

This research report categorizes the electroceuticals market by products, type, application and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the electroceuticals market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies; contracts, partnerships, agreements, new product launches, mergers and acquisitions, and recent developments associated with the electroceuticals market. Competitive analysis of upcoming startups in the electroceuticals market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall electroceuticals market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the electroceuticals market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the electroceuticals market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the electroceuticals market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the electroceuticals market.
  • Competitive Assessment: In-depth assessment of market ranking, growth strategies and product offerings of leading players like Medtronic plc (Ireland), Boston Scientific Corporation (US), Abbott Laboratories, Inc. (US), and Cochlear Ltd. (Australia) among others in the electroceuticals market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF STUDY
  • 1.3 STUDY SCOPE
    • FIGURE 1 ELECTROCEUTICALS MARKET SEGMENTATION
    • 1.3.1 GEOGRAPHIC SCOPE
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • TABLE 1 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (COMPANY REVENUE ESTIMATION APPROACH)
    • FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH (SEGMENTAL REVENUE ESTIMATION APPROACH)
    • FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
    • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: ELECTROCEUTICALS MARKET
  • 2.7 LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS
  • 2.8 IMPACT OF RECESSION ON ELECTROCEUTICALS MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 10 ELECTROCEUTICALS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
    • FIGURE 11 ELECTROCEUTICALS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 12 ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 13 ELECTROCEUTICALS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 ELECTROCEUTICALS MARKET OVERVIEW
    • FIGURE 14 RISING PREVALENCE OF NEUROLOGICAL AND CARDIOVASCULAR DISORDERS TO DRIVE MARKET
  • 4.2 ELECTROCEUTICALS MARKET SHARE, BY PRODUCT, 2024 VS. 2029
    • FIGURE 15 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS WILL CONTINUE TO DOMINATE MARKET IN 2029
  • 4.3 ELECTROCEUTICALS MARKET SHARE, BY TYPE, 2024 VS. 2029
    • FIGURE 16 IMPLANTABLE ELECTROCEUTICAL DEVICES TO DOMINATE MARKET IN 2024
  • 4.4 ELECTROCEUTICALS MARKET SHARE FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2024 VS. 2029
    • FIGURE 17 ARRHYTHMIA SEGMENT TO DOMINATE MARKET IN 2029
  • 4.5 ELECTROCEUTICALS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN ELECTROCEUTICALS MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 ELECTROCEUTICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising geriatric population and subsequent growth in prevalence of neurological and cardiovascular disorders
      • 5.2.1.2 Rising government support and funding for neurological disorders
      • 5.2.1.3 Increasing investments and funding for research on CRM devices
      • 5.2.1.4 Increasing focus on development of advanced neuromodulation and cardiac devices
      • 5.2.1.5 Increasing collaborations among device manufacturers, healthcare providers, and research institutes to develop neuromodulation and cardiac devices
      • 5.2.1.6 Availability of reimbursements for neuromodulation, cardiac devices, and cochlear implants
      • 5.2.1.7 Growing prevalence of hearing loss and increasing adoption of smart hearing aids
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of electroceutical devices
      • 5.2.2.2 Preference for drug therapies over neuromodulation and cardiac products
      • 5.2.2.3 Adverse effects and complications associated with neuromodulation, cardiac devices, and cochlear implants
    • TABLE 3 POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH DIFFERENT DEVICES
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets
      • 5.2.3.2 Development of ICDs and MRI-compatible ICDs and CRT-Ds
      • 5.2.3.3 Integration with digital health platforms
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Dearth of trained professionals
      • 5.2.4.2 Challenges associated with battery life and device replacement
      • 5.2.4.3 Complexity and infection issues related to electroceutical devices
    • 5.2.5 TRENDS
      • 5.2.5.1 Role of artificial intelligence (AI) in electroceutical devices
      • 5.2.5.2 Wearable and portable electroceuticals
  • 5.3 PRICING ANALYSIS
    • TABLE 4 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022)
    • TABLE 5 AVERAGE SELLING PRICE TREND FOR NEUROMODULATION DEVICES AND PROCEDURES, BY REGION (2022)
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 21 DIRECT DISTRIBUTION-PREFERRED STRATEGY FOR PROMINENT COMPANIES
  • 5.6 ECOSYSTEM ANALYSIS OF ELECTROCEUTICALS MARKET
    • FIGURE 22 ELECTROCEUTICALS MARKET: ECOSYSTEM ANALYSIS
    • 5.6.1 ROLE IN ECOSYSTEM
    • TABLE 6 ELECTROCEUTICALS MARKET: ROLE IN ECOSYSTEM
    • 5.6.2 KEY PLAYERS IN ELECTROCEUTICALS MARKET
    • FIGURE 23 ELECTROCEUTICALS MARKET: KEY PLAYERS
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 7 ELECTROCEUTICALS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 INTENSITY OF COMPETITIVE RIVALRY
    • 5.7.3 BARGAINING POWER OF BUYERS
    • 5.7.4 BARGAINING POWER OF SUPPLIERS
    • 5.7.5 THREAT OF SUBSTITUTES
  • 5.8 REGULATORY LANDSCAPE
    • 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING ELECTROCEUTICALS MARKET
    • 5.8.2 NORTH AMERICA
      • 5.8.2.1 US
    • TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.8.2.2 Canada
    • TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.8.3 EUROPE
    • 5.8.4 ASIA PACIFIC
      • 5.8.4.1 China
    • TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.8.4.2 Japan
      • 5.8.4.3 India
  • 5.9 TECHNOLOGY ANALYSIS
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT SCENARIO FOR PACEMAKERS
    • TABLE 13 IMPORT DATA FOR PACEMAKERS, BY COUNTRY, 2018-2022 (USD MILLION)
    • 5.10.2 EXPORT SCENARIO FOR PACEMAKERS
    • TABLE 14 EXPORT DATA FOR PACEMAKERS, BY COUNTRY, 2018-2022 (USD MILLION)
    • 5.10.3 IMPORT SCENARIO FOR COMPLIANT PRODUCTS
    • TABLE 15 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2018-2022 (USD MILLION)
    • 5.10.4 EXPORT SCENARIO FOR COMPLIANT PRODUCTS
    • TABLE 16 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2018-2022 (USD MILLION)
  • 5.11 PATENT ANALYSIS
    • FIGURE 24 ELECTROCEUTICALS MARKET: PATENT ANALYSIS OF CARDIAC PACEMAKERS
    • FIGURE 25 ELECTROCEUTICALS MARKET: PATENT ANALYSIS OF NEUROMODULATION PRODUCTS
  • 5.12 KEY CONFERENCES AND EVENTS
    • TABLE 17 LIST OF CONFERENCES & EVENTS, 2024-2025
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • FIGURE 26 REVENUE SHIFT FOR ELECTROCEUTICALS MARKET
  • 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
    • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
    • 5.14.2 BUYING CRITERIA
    • FIGURE 28 KEY BUYING CRITERIA FOR HOSPITALS

6 ELECTROCEUTICALS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 19 ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
  • 6.2 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
    • 6.2.1 INTRODUCTION OF LEADLESS AND MRI-SAFE PACEMAKERS & DEFIBRILLATORS TO BOOST MARKET GROWTH
    • TABLE 20 KEY PRODUCTS IN CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET
    • TABLE 21 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 22 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 23 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 24 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 25 MIDDLE EAST & AFRICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 6.3 COCHLEAR IMPLANTS
    • 6.3.1 INCREASING PREVALENCE OF HEARING LOSS TO DRIVE DEMAND
    • TABLE 26 KEY PRODUCTS IN COCHLEAR IMPLANTS MARKET
    • TABLE 27 COCHLEAR IMPLANTS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 28 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 29 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 30 ASIA PACIFIC: COCHLEAR IMPLANTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 31 MIDDLE EAST & AFRICA: COCHLEAR IMPLANTS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 6.4 NEUROMODULATORS
    • TABLE 32 NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 33 NEUROMODULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 34 NORTH AMERICA: NEUROMODULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 35 EUROPE: NEUROMODULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 36 ASIA PACIFIC: NEUROMODULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 37 MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • 6.4.1 SPINAL CORD STIMULATORS
      • 6.4.1.1 Growing incidence of spinal cord injuries to support market growth
    • TABLE 38 KEY SPINAL CORD STIMULATOR DEVICES AVAILABLE IN MARKET
    • TABLE 39 SPINAL CORD STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 40 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 41 EUROPE: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 42 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 43 MIDDLE EAST & AFRICA: SPINAL CORD STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • 6.4.2 DEEP BRAIN STIMULATORS
      • 6.4.2.1 Widely used to control debilitating symptoms caused by movement and neurological disorders
    • TABLE 44 KEY DEEP BRAIN STIMULATOR DEVICES AVAILABLE IN MARKET
    • TABLE 45 DEEP BRAIN STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 46 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 47 EUROPE: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 48 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 49 MIDDLE EAST & AFRICA: DEEP BRAIN STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • 6.4.3 VAGUS NERVE STIMULATORS
      • 6.4.3.1 High incidence of epilepsy to drive market
    • TABLE 50 KEY VAGUS NERVE STIMULATOR DEVICES AVAILABLE IN MARKET
    • TABLE 51 VAGUS NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 52 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 53 EUROPE: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 54 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 55 MIDDLE EAST & AFRICA: VAGUS NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • 6.4.4 SACRAL NERVE STIMULATORS
      • 6.4.4.1 Widening scope of sacral nerve stimulation to drive growth
    • TABLE 56 KEY SACRAL NERVE STIMULATOR DEVICES AVAILABLE IN MARKET
    • TABLE 57 SACRAL NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 58 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 59 EUROPE: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 60 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 61 MIDDLE EAST & AFRICA: SACRAL NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • 6.4.5 GASTRIC ELECTRICAL STIMULATORS
      • 6.4.5.1 Growing number of people suffering from severe GERD and gastroparesis to fuel market growth
    • TABLE 62 GASTRIC ELECTRICAL STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 63 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 64 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 65 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 66 MIDDLE EAST & AFRICA: GASTRIC ELECTRICAL STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • 6.4.6 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS
      • 6.4.6.1 Extensive use in healthcare, low cost, and ease of use to favor market growth
    • TABLE 67 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 68 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 69 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 70 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 71 MIDDLE EAST & AFRICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • 6.4.7 TRANSCRANIAL MAGNETIC STIMULATORS
      • 6.4.7.1 Minimal patient discomfort associated with TMS to support demand
    • TABLE 72 TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 73 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 74 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 76 MIDDLE EAST & AFRICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • 6.4.8 RESPIRATORY ELECTRICAL STIMULATORS
      • 6.4.8.1 Increasing incidence of spinal cord injuries to drive market
    • TABLE 77 RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 78 NORTH AMERICA: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 79 EUROPE: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 80 ASIA PACIFIC: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 81 MIDDLE EAST & AFRICA: RESPIRATORY ELECTRICAL STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • 6.4.9 TRIGEMINAL NERVE STIMULATORS
      • 6.4.9.1 High treatment efficacy to fuel market growth
    • TABLE 82 TRIGEMINAL NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 83 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 84 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 85 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 86 MIDDLE EAST & AFRICA: TRIGEMINAL NERVE STIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • 6.4.10 RESPONSIVE NEUROSTIMULATORS
      • 6.4.10.1 Targeted and personalized treatment to fuel market growth
    • TABLE 87 RESPONSIVE NEUROSTIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 88 NORTH AMERICA: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 89 EUROPE: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 90 ASIA PACIFIC: RESPONSIVE NEUROSTIMULATORS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 91 MIDDLE EAST & AFRICA: RESPONSIVE NEUROSTIMULATORS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 6.5 RETINAL IMPLANTS
    • 6.5.1 GROWING NUMBER OF RETINITIS PIGMENTOSA CASES TO SUPPORT MARKET GROWTH
    • TABLE 92 RETINAL IMPLANTS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 93 NORTH AMERICA: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 94 EUROPE: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: RETINAL IMPLANTS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 96 MIDDLE EAST & AFRICA: RETINAL IMPLANTS MARKET, BY REGION, 2021-2029 (USD MILLION)

7 ELECTROCEUTICALS MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 97 ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
  • 7.2 IMPLANTABLE ELECTROCEUTICAL DEVICES
    • 7.2.1 LONG-TERM COST SAVINGS TO DRIVE MARKET
    • TABLE 98 IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 99 NORTH AMERICA: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 100 EUROPE: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 101 ASIA PACIFIC: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 102 MIDDLE EAST & AFRICA: IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 7.3 NONINVASIVE ELECTROCEUTICAL DEVICES
    • 7.3.1 EXTENSIVE USE IN HEALTHCARE, EASE OF USE, AND LOW COST TO SUPPORT MARKET GROWTH
    • TABLE 103 NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 104 NORTH AMERICA: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 105 EUROPE: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 106 ASIA PACIFIC: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 107 MIDDLE EAST & AFRICA: NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2021-2029 (USD MILLION)

8 ELECTROCEUTICALS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), BY APPLICATION
    • TABLE 108 ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 8.2.1 ARRHYTHMIA
      • 8.2.1.1 Increasing prevalence of arrhythmia to support market growth
    • TABLE 109 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 110 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 111 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR ARRHYTHMIA, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.2.2 HEART FAILURE
      • 8.2.2.1 Rising prevalence of heart-related conditions in older individuals to drive growth
    • TABLE 113 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 114 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 115 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 116 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR HEART FAILURE, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.2.3 OTHER CARDIAC PACEMAKER & ICD APPLICATIONS
    • TABLE 117 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 118 NORTH AMERICA: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 119 EUROPE: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.3 ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION
    • TABLE 121 ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 8.3.1 CHRONIC PAIN
      • 8.3.1.1 High incidence of chronic pain to support market growth
    • TABLE 122 SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 123 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 124 EUROPE: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.3.2 FAILED BACK SURGERY SYNDROME
      • 8.3.2.1 Increasing incidence of FBSS to drive demand
    • TABLE 126 SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 127 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 128 EUROPE: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 129 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.3.3 ISCHEMIA
      • 8.3.3.1 High effectiveness of neuromodulation for ischemia treatment to propel market
    • TABLE 130 SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 131 NORTH AMERICA: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 132 EUROPE: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 133 ASIA PACIFIC: SPINAL CORD STIMULATORS MARKET FOR ISCHEMIA, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.4 ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION
    • TABLE 134 ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 8.4.1 PARKINSON'S DISEASE
      • 8.4.1.1 Rising incidence of Parkinson's disease and growing R&D to drive market
    • TABLE 135 DEEP BRAIN STIMULATORS MARKET FOR PARKINSON'S DISEASE, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 136 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 137 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 138 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.4.2 TREMORS
      • 8.4.2.1 High efficacy of DBS in treating tremors to drive market
    • TABLE 139 DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 140 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 141 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 142 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.4.3 DEPRESSION
      • 8.4.3.1 Rising research and clinical studies related to depression treatment to propel market
    • TABLE 143 DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 144 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 145 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 146 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.4.4 OTHER DBS APPLICATIONS
    • TABLE 147 DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 148 NORTH AMERICA: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 149 EUROPE: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 150 ASIA PACIFIC: DEEP BRAIN STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.5 ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION
    • TABLE 151 ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 8.5.1 URINE INCONTINENCE
      • 8.5.1.1 High incidence of urine incontinence to offer growth opportunities for market players
    • TABLE 152 SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 153 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 154 EUROPE: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 155 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET FOR URINE INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.5.2 FECAL INCONTINENCE
      • 8.5.2.1 Reduced symptom recurrence with use of SNS to drive demand
    • TABLE 156 SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 157 NORTH AMERICA: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 158 EUROPE: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 159 ASIA PACIFIC: SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.6 ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION
    • TABLE 160 ELECTROCEUTICALS MARKET FOR VAGUS NERVE SIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 8.6.1 EPILEPSY
      • 8.6.1.1 Advantages associated with VNS in epilepsy treatment to propel market
    • TABLE 161 VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 162 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 163 EUROPE: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 164 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.6.2 OTHER VNS APPLICATIONS
    • TABLE 165 VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 166 NORTH AMERICA: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 167 EUROPE: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 168 ASIA PACIFIC: VAGUS NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.7 ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION
    • TABLE 169 ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 8.7.1 GASTROPARESIS
      • 8.7.1.1 Reduced hospitalization time associated with GES treatment to drive market
    • TABLE 170 GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 171 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 172 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 173 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.7.2 OBESITY
      • 8.7.2.1 High prevalence of obesity and risks associated with gastric bypass to propel market
    • TABLE 174 GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 175 NORTH AMERICA: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 176 EUROPE: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 177 ASIA PACIFIC: GASTRIC ELECTRICAL STIMULATORS MARKET FOR OBESITY, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.8 ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION
    • TABLE 178 ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 8.8.1 TREATMENT-RESISTANT DEPRESSION
      • 8.8.1.1 High prevalence of depression to drive market
    • TABLE 179 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 180 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 181 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 182 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.8.2 OTHER TENS APPLICATIONS
    • TABLE 183 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 184 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, 2021-2029 (USD MILLION)
    • TABLE 185 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 186 ASIA PACIFIC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.9 ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION
    • TABLE 187 ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION
    • 8.9.1 DEPRESSION
      • 8.9.1.1 High effectiveness of TMS and increased acceptance among patients to drive market
    • TABLE 188 TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 189 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 190 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 191 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR DEPRESSION, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.9.2 MIGRAINE
      • 8.9.2.1 High prevalence of migraine to support market growth
    • TABLE 192 TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 193 NORTH AMERICA: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 194 EUROPE: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 195 ASIA PACIFIC: TRANSCRANIAL MAGNETIC STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
  • 8.10 ELECTROCEUTICALS MARKET FOR RESPIRATORY ELECTRICAL STIMULATORS, BY APPLICATION
    • 8.10.1 SPINAL CORD INJURY
      • 8.10.1.1 Rising incidence of spinal cord injuries to fuel demand
    • TABLE 196 RESPIRATORY ELECTRICAL STIMULATORS MARKET FOR SPINAL CORD INJURY, BY REGION, 2021-2029 (USD MILLION)
  • 8.11 ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION
    • TABLE 197 ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION
    • 8.11.1 ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
      • 8.11.1.1 Minimal side effects to drive adoption
    • TABLE 198 TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 199 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 200 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 201 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, BY COUNTRY, 2021-2029 (USD MILLION)
    • 8.11.2 MIGRAINE
      • 8.11.2.1 Increasing demand for non-pharmacological treatments to support market growth
    • TABLE 202 TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 203 NORTH AMERICA: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 204 EUROPE: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 205 ASIA PACIFIC: TRIGEMINAL NERVE STIMULATORS MARKET FOR MIGRAINE, BY COUNTRY, 2021-2029 (USD MILLION)

9 ELECTROCEUTICALS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 206 ELECTROCEUTICALS MARKET, BY REGION, 2021-2029 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 29 NORTH AMERICA: ELECTROCEUTICALS MARKET SNAPSHOT
    • TABLE 207 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 208 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 209 NORTH AMERICA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 210 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 211 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 212 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 213 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 214 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 215 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 216 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 217 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 218 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 219 NORTH AMERICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Rising prevalence of cardiovascular and neurological disorders to drive market
    • TABLE 220 US: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 221 US: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 222 US: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 223 US: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 224 US: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 225 US: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 226 US: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 227 US: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 228 US: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 229 US: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 230 US: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 231 US: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Rising healthcare expenditure and increasing prevalence of chronic diseases to drive demand
    • TABLE 232 NEUROLOGICAL CONDITIONS PREVALENT IN CANADA, 2016-2031
    • TABLE 233 CANADA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 234 CANADA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 235 CANADA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 236 CANADA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 237 CANADA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 238 CANADA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 239 CANADA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 240 CANADA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 241 CANADA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 242 CANADA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 243 CANADA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 244 CANADA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.2.3 NORTH AMERICA: RECESSION IMPACT
  • 9.3 EUROPE
    • TABLE 245 EUROPE: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 246 EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 247 EUROPE: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 248 EUROPE: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 249 EUROPE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 250 EUROPE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 251 EUROPE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 252 EUROPE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 253 EUROPE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 254 EUROPE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 255 EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 256 EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 257 EUROPE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Presence of favorable reimbursement policies to drive market
    • TABLE 258 GERMANY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 259 GERMANY: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 260 GERMANY: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 261 GERMANY: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 262 GERMANY: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 263 GERMANY: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 264 GERMANY: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 265 GERMANY: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 266 GERMANY: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 267 GERMANY: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 268 GERMANY: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 269 GERMANY: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Rising support from government and private organizations to fuel market growth
    • TABLE 270 UK: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 271 UK: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 272 UK: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 273 UK: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 274 UK: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 275 UK: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 276 UK: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 277 UK: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 278 UK: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 279 UK: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 280 UK: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 281 UK: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Promising healthcare reforms to drive market
    • TABLE 282 FRANCE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 283 FRANCE: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 284 FRANCE: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 285 FRANCE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 286 FRANCE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 287 FRANCE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 288 FRANCE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 289 FRANCE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 290 FRANCE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 291 FRANCE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 292 FRANCE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 293 FRANCE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Easy access to healthcare services to create lucrative opportunities for market growth
    • TABLE 294 ITALY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 295 ITALY: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 296 ITALY: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 297 ITALY: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 298 ITALY: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 299 ITALY: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 300 ITALY: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 301 ITALY: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 302 ITALY: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 303 ITALY: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 304 ITALY: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 305 ITALY: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing number of conferences and awareness programs to support market growth
    • TABLE 306 SPAIN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 307 SPAIN: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 308 SPAIN: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 309 SPAIN: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 310 SPAIN: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 311 SPAIN: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 312 SPAIN: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 313 SPAIN: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 314 SPAIN: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 315 SPAIN: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 316 SPAIN: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 317 SPAIN: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 318 REST OF EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 319 REST OF EUROPE: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 320 REST OF EUROPE: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 321 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 322 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 323 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 324 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 325 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 326 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 327 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 328 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 329 REST OF EUROPE: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.3.7 EUROPE: RECESSION IMPACT
  • 9.4 ASIA PACIFIC
    • FIGURE 30 ASIA PACIFIC: ELECTROCEUTICALS MARKET SNAPSHOT
    • TABLE 330 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY COUNTRY, 2021-2029 (USD MILLION)
    • TABLE 331 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 332 ASIA PACIFIC: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 333 ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 334 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 335 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 336 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 337 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 338 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 339 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 340 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 341 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 342 ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Increasing prevalence of cardiovascular and neurological disorders to drive demand
    • TABLE 343 JAPAN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 344 JAPAN: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 345 JAPAN: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 346 JAPAN: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 347 JAPAN: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 348 JAPAN: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 349 JAPAN: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 350 JAPAN: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 351 JAPAN: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 352 JAPAN: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 353 JAPAN: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 354 JAPAN: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Rising geriatric population to support market growth
    • TABLE 355 CHINA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 356 CHINA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 357 CHINA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 358 CHINA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 359 CHINA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 360 CHINA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 361 CHINA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 362 CHINA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 363 CHINA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 364 CHINA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 365 CHINA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 366 CHINA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Developments in healthcare structure to propel market
    • TABLE 367 INDIA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 368 INDIA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 369 INDIA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 370 INDIA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 371 INDIA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 372 INDIA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 373 INDIA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 374 INDIA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 375 INDIA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 376 INDIA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 377 INDIA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 378 INDIA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 379 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 380 REST OF ASIA PACIFIC: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 381 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 382 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 383 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 384 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 385 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 386 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 387 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 388 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 389 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 390 REST OF ASIA PACIFIC: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.4.5 ASIA PACIFIC: RECESSION IMPACT
  • 9.5 LATIN AMERICA
    • 9.5.1 RAPIDLY GROWING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
    • TABLE 391 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 392 LATIN AMERICA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 393 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 394 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 395 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 396 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 397 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 398 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 399 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 400 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 401 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 402 LATIN AMERICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.5.2 LATIN AMERICA: RECESSION IMPACT
  • 9.6 MIDDLE EAST & AFRICA
    • TABLE 403 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY REGION, 2021-2029 (USD MILLION)
    • TABLE 404 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 405 MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 406 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 407 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 408 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR SPINAL CORD STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 409 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR DEEP BRAIN STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 410 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR SACRAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 411 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR VAGUS NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 412 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 413 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 414 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRANSCRANIAL MAGNETIC STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • TABLE 415 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET FOR TRIGEMINAL NERVE STIMULATORS, BY APPLICATION, 2021-2029 (USD MILLION)
    • 9.6.1 GCC COUNTRIES
      • 9.6.1.1 Advances in healthcare sector to support market growth
    • TABLE 416 GCC COUNTRIES: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 417 GCC COUNTRIES: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 418 GCC COUNTRIES: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • 9.6.2 REST OF MIDDLE EAST & AFRICA
    • TABLE 419 REST OF MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2021-2029 (USD MILLION)
    • TABLE 420 REST OF MIDDLE EAST & AFRICA: NEUROMODULATORS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • TABLE 421 REST OF MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY TYPE, 2021-2029 (USD MILLION)
    • 9.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
    • TABLE 422 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
  • 10.3 REVENUE ANALYSIS
    • FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN ELECTROCEUTICALS MARKET
  • 10.4 MARKET SHARE ANALYSIS
    • TABLE 423 ELECTROCEUTICALS MARKET: DEGREE OF COMPETITION
  • 10.5 BRAND/PRODUCT COMPARISON
    • FIGURE 32 ELECTROCEUTICALS MARKET: BRAND COMPARISON, BY KEY PLAYER
  • 10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS
    • 10.6.1 STARS
    • 10.6.2 EMERGING LEADERS
    • 10.6.3 PERVASIVE PLAYERS
    • 10.6.4 PARTICIPANTS
    • FIGURE 33 ELECTROCEUTICALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
  • 10.7 COMPANY FOOTPRINT
    • TABLE 424 PRODUCT FOOTPRINT
    • TABLE 425 REGIONAL FOOTPRINT
    • TABLE 426 OVERALL COMPANY FOOTPRINT
  • 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES
    • 10.8.1 PROGRESSIVE COMPANIES
    • 10.8.2 STARTING BLOCKS
    • 10.8.3 RESPONSIVE COMPANIES
    • 10.8.4 DYNAMIC COMPANIES
    • FIGURE 34 ELECTROCEUTICALS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/ SMES), 2022
  • 10.9 COMPETITIVE BENCHMARKING
    • TABLE 427 ELECTROCEUTICALS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
    • TABLE 428 PRODUCT FOOTPRINT (STARTUPS/SMES)
    • TABLE 429 REGIONAL FOOTPRINT (STARTUPS/SMES)
    • TABLE 430 OVERALL COMPANY FOOTPRINT (STARTUPS/SMES)
  • 10.10 COMPETITIVE SCENARIO
    • 10.10.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 431 PRODUCT LAUNCHES & APPROVALS
    • 10.10.2 DEALS
    • TABLE 432 DEALS

11 COMPANY PROFILES

  • (Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)**
  • 11.1 KEY PLAYERS
    • 11.1.1 MEDTRONIC
    • TABLE 433 MEDTRONIC: BUSINESS OVERVIEW
    • FIGURE 35 MEDTRONIC: COMPANY SNAPSHOT (2023)
    • 11.1.2 BOSTON SCIENTIFIC CORPORATION
    • TABLE 434 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
    • FIGURE 36 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.3 ABBOTT
    • TABLE 435 ABBOTT: BUSINESS OVERVIEW
    • FIGURE 37 ABBOTT: COMPANY SNAPSHOT (2022)
    • 11.1.4 LIVANOVA PLC
    • TABLE 436 LIVANOVA PLC: BUSINESS OVERVIEW
    • FIGURE 38 LIVANOVA PLC: COMPANY SNAPSHOT (2022)
    • 11.1.5 COCHLEAR LTD.
    • TABLE 437 COCHLEAR LTD.: BUSINESS OVERVIEW
    • FIGURE 39 COCHLEAR LTD.: COMPANY SNAPSHOT (2023)
    • 11.1.6 MICROPORT SCIENTIFIC CORPORATION
    • TABLE 438 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
    • FIGURE 40 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.7 SONOVA
    • TABLE 439 SONOVA: BUSINESS OVERVIEW
    • FIGURE 41 SONOVA GROUP: COMPANY SNAPSHOT (2022)
    • 11.1.8 NEVRO CORP.
    • TABLE 440 NEVRO CORP.: BUSINESS OVERVIEW
    • FIGURE 42 NEVRO CORP.: COMPANY SNAPSHOT (2022)
    • 11.1.9 AXONICS, INC.
    • TABLE 441 AXONICS, INC.: BUSINESS OVERVIEW
    • FIGURE 43 AXONICS INC.: COMPANY SNAPSHOT (2022)
    • 11.1.10 NEURONETICS
    • TABLE 442 NEURONETICS: BUSINESS OVERVIEW
    • FIGURE 44 NEURONETICS: COMPANY SNAPSHOT (2022)
    • 11.1.11 ELECTROCORE, INC.
    • TABLE 443 ELECTROCORE, INC.: BUSINESS OVERVIEW
    • FIGURE 45 ELECTROCORE, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.12 NEUROPACE, INC.
    • TABLE 444 NEUROPACE, INC.: BUSINESS OVERVIEW
    • FIGURE 46 NEUROPACE, INC.: COMPANY SNAPSHOT (2022)
  • 11.2 OTHER PLAYERS
    • 11.2.1 BIOTRONIK
    • TABLE 445 BIOTRONIK: COMPANY OVERVIEW
    • 11.2.2 MEDICO S.R.L.
    • TABLE 446 MEDICO S.R.L.: COMPANY OVERVIEW
    • 11.2.3 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.
    • TABLE 447 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
    • 11.2.4 MED-EL
    • TABLE 448 MED-EL: COMPANY OVERVIEW
    • 11.2.5 ALEVA NEUROTHERAPEUTICS
    • TABLE 449 ALEVA NEUROTHERAPEUTICS: COMPANY OVERVIEW
    • 11.2.6 NEUROSIGMA, INC.
    • TABLE 450 NEUROSIGMA, INC.: COMPANY OVERVIEW
    • 11.2.7 BIOWAVE CORPORATION
    • TABLE 451 BIOWAVE CORPORATION: COMPANY OVERVIEW
    • 11.2.8 SOTERIX MEDICAL INC.
    • TABLE 452 SOTERIX MEDICAL INC.: COMPANY OVERVIEW
    • 11.2.9 BIOINDUCTION (AMBER THERAPEUTICS)
    • TABLE 453 BIOINDUCTION (AMBER THERAPEUTICS): COMPANY OVERVIEW
    • 11.2.10 GIMER MEDICAL
    • TABLE 454 GIMER MEDICAL: COMPANY OVERVIEW
    • 11.2.11 CEFALY
    • TABLE 455 CEFALY: COMPANY OVERVIEW
    • 11.2.12 BIOCONTROL MEDICAL
    • TABLE 456 BIOCONTROL MEDICAL: COMPANY OVERVIEW
    • 11.2.13 TVNS HEALTH GMBH
    • TABLE 457 TVNS HEALTH GMBH: COMPANY OVERVIEW
  • *Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)** might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS